Guo-Fu Li

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 19

Top Topics

Clinical Practice

Respiratory Syndrome Coronavirus

Top Venues

European journal of drug metabolism and pharmacokinetics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

European journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Guo-Fu Li, Yu-Wei Qiao, Ai-Jia Guan, Guo Yu
Informative Censoring of Progression-Free Survival Data in TROPiCS-02 Trial: An Unrecognized Bias. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Guo Yu, Na Zhang, Ai-Jia Guan, Yu-Wei Qiao, Guo-Fu Li
Validity of Meta-Analytical Estimates and Hazard Ratios Quantifying Survival Benefit of Immunochemotherapy in Low PD-L1-Expressing Esophageal Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Guo-Fu Li, Yu-Wei Qiao, Ai-Jia Guan, Guo Yu
Informative Censoring of Progression-Free Survival Data in the TROPiCS-02 Trial: An Unrecognized Bias. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Danna Wu, Guo-Fu Li
Improving Report of ADAURA Trial by Distinguishing Treatment-Related Adverse Events From Treatment-Emergent Adverse Events and Assessing Independence of Censoring in Final Disease-Free Survival Analyses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Xiang Chen, Guo Yu, Guo-Fu Li
Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate. European journal of drug metabolism and pharmacokinetics (2023)
Guo-Fu Li, Yu-Wei Qiao, Ai-Jia Guan, Guo Yu
Informative Censoring of Progression-Free Survival Data in the TROPiCS-02 Trial: An Unrecognized Bias. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Dan-Na Wu, Guo Yu, Guo-Fu Li
Reproducing prolonged time to peak bisoprolol concentration by PBPK modeling with lysosomal trapping in enterocytes. CPT: pharmacometrics & systems pharmacology 11 (1) (2022)
Dan-Na Wu, Li-Rong Jiao, Guo-Fu Li, Guo Yu
Non-peer-reviewed data, effect measures, and meta-regression analysis on proton pump inhibitor use and COVID-19. European journal of clinical pharmacology 78 (8) (2022)
Yichao Yu, Qi-Qi Zhao, Guo-Fu Li
Prediction of Non-Linear Pharmacokinetics of Monoclonal Antibodies in Human from Nonclinical Data: Are We There Yet? European journal of drug metabolism and pharmacokinetics 46 (4) (2021)
Dan-Na Wu, Guo-Fu Li, Guo Yu
Use of proton pump inhibitors and adverse clinical outcomes. British journal of clinical pharmacology 88 (5) (2021)
Xiao-Xiao An, Yichao Yu, Guo-Fu Li, Guo Yu
Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis. European journal of drug metabolism and pharmacokinetics 46 (2) (2021)
Guo-Fu Li, Xiao-Xiao An, Yichao Yu, Li-Rong Jiao, Daniele Canarutto, Guo Yu, Guangji Wang, Dan-Na Wu, Yin Xiao
Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis. Gut 70 (9) (2020)
Jia-Qin Gu, Yun-Peng Guo, Zheng Jiao, Jun-Jie Ding, Guo-Fu Li
How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective. European journal of drug metabolism and pharmacokinetics 45 (2) (2020)
Guo Yu, Guo-Fu Li
Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective. European journal of drug metabolism and pharmacokinetics 45 (1) (2020)
Guo-Fu Li, Qing-Shan Zheng, Yichao Yu, Wei Zhong, Hong-Hao Zhou, Furong Qiu, Guangji Wang, Guo Yu, Hartmut Derendorf
Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults. Clinical pharmacokinetics 58 (7) (2020)
Junyi Wu, Chen Wang, Guo-Fu Li, En-Tzu Tang, Qingshan Zheng
Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model-based meta-analysis. British journal of clinical pharmacology 87 (3) (2020)
Jun-Yi Wu, Guo Yu, Guo-Fu Li
Model-Informed Approaches for Alternative Aripiprazole Dosing Regimens and Missed Dose Management: Towards Better Adherence to Antipsychotic Pharmacotherapy. European journal of drug metabolism and pharmacokinetics 43 (4) (2019)
Guo Yu, Dan-Na Wu, Yan Gong, Guo-Fu Li, Hong-Hao Zhou
Conflicting meal recommendations for oral oncology drugs: pose risks to patient care? European journal of clinical pharmacology 74 (6) (2018)
Guo Yu, Hong-Hao Zhou, Qing-Shan Zheng, Guo-Fu Li
Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese. European journal of clinical pharmacology 75 (4) (2018)